| 产品描述: | Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS-MS biochemical assay, IC50 of 16.6 nM in Fluorescence biochemical assay. Target: Mutant IDH1 Mutant IDH1-IN-2 has a neomorphic activity and in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer. More bioactivity information in Patent WO 2013046136A1 (Example 224). |
| 靶点: |
Isocitrate Dehydrogenase (IDH);IsocitrateDehydrogenase(IDH) |
| 参考文献: |
1. Huangshu, et al. 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH and their preparation. WO2013046136A1 |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.176 ml |
10.881 ml |
21.761 ml |
| 5 mM |
0.435 ml |
2.176 ml |
4.352 ml |
| 10 mM |
0.218 ml |
1.088 ml |
2.176 ml |
| 50 mM |
0.044 ml |
0.218 ml |
0.435 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |